Abstract
Massive bleeding is a serious medical complication arising from trauma, surgery, and invasive procedures. In this case, timely and effective hemostasis must be applied to patients. The aim of this study is to compare transfusion therapies guided by thromboelastogram (TEG) and conventional coagulation tests (CCTs) during orthopedic surgery, focusing on blood-component transfusion and coagulation function of patients. The patients who underwent orthopedic surgery in our hospital from May 2019 to November 2020 were retrospectively analyzed. According to different transfusion-guiding strategies, the patients were assigned into the CCT group containing 214 patients and the TEG group containing 266 patients. The TEG group used fewer volumes of blood products including red blood cell (RBC) suspension, fresh-frozen plasma, cryoprecipitate, and apheresis platelets than the CCT group ( P < 0.05 ). After orthopedic surgery, the hemoglobin (Hb) and RBC counts were decreased, but the white blood cell (WBC) counts were increased in all patients receiving whether transfusion therapy guided by TEG or CCTs. Importantly, the TEG group exhibited fewer WBC counts concomitant with higher Hb and more RBC counts than the CCT group ( P < 0.05 ). There was no significant difference on the platelet (PLT) counts between the two groups before and after orthopedic surgery ( P > 0.05 ). Significant declines on thrombin time (TT), partial activated thromboplastin time (PATT), prothrombin time (PT), and d-dimer (D-D), along with an increase on fibrinogen (FIB) were observed in two groups after surgery. The TEG group showed reduced TT, PATT, PT, D-D, and elevated FIB compared to the CCT group ( P < 0.05 ). Posttransfusion, the K value (time to reach a certain clot strength) and R value (coagulation reaction time) were decreased, the angle (α) value (clot formation rate), MA value (maximum amplitude), and CI (coagulation index) were increased in the TEG group ( P < 0.05 ). When the liver function was assessed, it was found that the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total serum bilirubin (TBIL) were increased significantly, and albumin (ALB) was decreased between the two groups after surgery, but the TEG group with lower levels of ALT, AST, and TBIL and a higher level of ALB than the CCT group ( P < 0.05 ). With regard to the renal function, two groups had increased levels of serum creatinine (Scr) and blood urea nitrogen (BUN) with a declined uric acid (UA) level after surgery; however, the patients in the TEG group had lower levels of Scr and BUN and a higher level of UA compared to the CCT group ( P < 0.05 ). In view of above data, TEG-guided transfusion therapy could reduce use of blood products, optimize blood components, and improve coagulation function for patients undergoing orthopedic surgery. TEG-guided transfusion therapy may prevent liver and renal dysfunction after orthopedic surgery.
Highlights
Massive blood lose is a risk for mortality and morbidity during orthopedic surgeries [1], including total hip replacement, total knee replacement [2], and spine surgery [3]
Significant declines on thrombin time (TT), partial activated thromboplastin time (PATT), prothrombin time (PT), and D-D, along with an increase on FIB were observed in two groups after surgery
Some studies have shown that the TEG group reduced the consumption of blood products in the surgical surgery and severe coagulopathy [23,24,25], which were similar to our study, and the usage of red blood cell (RBC) suspension, fresh-frozen plasma, cryoprecipitate and apheresis platelet in the TEG group was significantly reduced compared to the Conventional coagulation tests (CCTs) group, but a study about liver transplantation indicated that the TEG group did not reduce intraoperative blood product consumption [26]
Summary
Massive blood lose is a risk for mortality and morbidity during orthopedic surgeries [1], including total hip replacement, total knee replacement [2], and spine surgery [3]. Massive bleeding is a serious and life-threatening manifestation, which can cause a variety of complications, including coagulation abnormalities, immunosuppression, infection, hypothermia, and organ damage related with massive transfusion of blood products [4, 5]. Blood transfusion involves red blood cell (RBC) suspension, fresh-frozen plasma, cryoprecipitate, and apheresis platelets, which is critical to the patients with massive. The present massive blood transfusion protocol is fixed infusion of RBC, fresh frozen plasma (FFP), and platelets (PLTs) at a ratio of 1 : 1 : 1, likely leading to a huge waste. There is limited evidence supporting its application in orthopedic surgery, and this study attempts to compare transfusion therapies guided by TEG and CCTs during orthopedic surgery, with a specific focus on bloodcomponent transfusion and coagulation function of patients
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
